中重度创伤性脑损伤血肿扩大的时间进程与临床意义:一项观察性队列研究
本单中心、基于人群的观察性队列研究纳入643例中重度TBI成人患者,用半自动三维容积分割计算血肿体积,血肿扩大定义为从基线CT至病灶停止进展的体积变化,以12个月GOS评估功能结局。基线平均血肿体积4.2 ml,随后平均扩大3.8 ml;33%的血肿在3小时内停止进展,94%在伤后24小时内停止进展;脑挫裂伤比轴外血肿扩大更显著且持续时间更长。校正已知结局预测因素后,血肿扩大与12个月GOS呈显著剂量-反应关系,血肿体积每增加1 ml,GOS降低1分的风险增加6%。作者认为血肿扩大是TBI不良结局的驱动因素,并提出比既往建议更宽的预防病灶进展时间窗。
要点
- 643例中重度TBI成人中,基线平均血肿体积4.2 ml,随后平均扩大3.8 ml。
- 33%的血肿在伤后3小时内停止进展,94%在伤后24小时内停止进展。
- 脑挫裂伤比轴外血肿扩大更显著且持续时间更长。
- 校正已知结局预测因素后,血肿体积每增加1 ml,12个月GOS降低1分的风险增加6%。
- 作者认为血肿扩大是TBI不良结局的驱动因素,并提出比既往建议更宽的预防病灶进展时间窗。
适用人群与场景
- 中重度创伤性脑损伤成人患者,单中心、基于人群的观察性队列。
诊断标准与关键阈值
- 血肿扩大定义为从基线CT扫描至病灶停止进展的血肿体积变化,体积用半自动容积分割计算。
- 功能结局用12个月格拉斯哥结局量表(GOS)测量。
研究设计与关键结果
- 研究类型:单中心、基于人群的观察性队列研究;样本量643例中重度TBI成人。
- 基线平均血肿体积4.2 ml,随后平均血肿扩大3.8 ml。
- 33%的血肿在伤后3小时内停止进展,94%的血肿在伤后24小时内停止进展。
- 脑挫裂伤比轴外血肿扩大更显著且持续时间更长。
- 校正已知结局预测因素后,血肿扩大与12个月GOS呈显著剂量-反应关系:血肿体积每增加1 ml,GOS降低1分的风险增加6%。
证据类型、等级与局限
- 证据类型:单中心、基于人群的观察性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为血肿扩大是TBI不良结局的驱动因素,血肿体积的小变化也影响功能结局。
- 作者提出比既往建议更宽的预防病灶进展时间窗。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Preventing intracranial hematoma expansion has been advertised as a possible treatment opportunity in traumatic brain injury (TBI). However, the time course of hematoma expansion, and whether the expansion affects outcome, remains poorly understood. In light of this, the aim of this study was to use 3D volume rendering to determine how traumatic intracranial hematomas expand over time and evaluate its impact on outcome.
METHODS: Single-center, population-based, observational cohort study of adults with moderate-to-severe TBI. Hematoma expansion was defined as the change in hematoma volume from the baseline computed tomography scan until the lesion had stopped progressing. Volumes were calculated by using semiautomated volumetric segmentation. Functional outcome was measured by using the 12 month Glasgow outcome scale (GOS).
RESULTS: In total, 643 patients were included. The mean baseline hematoma volume was 4.2 ml, and the subsequent mean hematoma expansion was 3.8 ml. Overall, 33% of hematomas had stopped progressing within 3 h, and 94% of hematomas had stopped progressing within 24 h of injury. Contusions expanded significantly more, and for a longer period of time, than extra-axial hematomas. There was a significant dose-response relationship between hematoma expansion and 12 month GOS, even after adjusting for known outcome predictors, with every 1-ml increase in hematoma volume associated with a 6% increased risk of 1-point GOS deduction.
CONCLUSIONS: Hematoma expansion is a driver of unfavorable outcome in TBI, with small changes in hematoma volume also impacting functional outcome. This study also proposes a wider window of opportunity to prevent lesion progression than what has previously been suggested.
参考来源
- Fletcher-Sandersjöö A, Tatter C, Tjerkaski J, et al. Time Course and Clinical Significance of Hematoma Expansion in Moderate-to-Severe Traumatic Brain Injury: An Observational Cohort Study. Neurocrit Care. 2022. PMID: 36167951. doi:10.1007/s12028-022-01609-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。